» Articles » PMID: 1008826

Human Liver Glycogen Phosphorylase. Kinetic Properties and Assay in Biopsy Specimens

Overview
Journal Biochem J
Specialty Biochemistry
Date 1976 Dec 1
PMID 1008826
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

1. The two forms of glycogen phosphorylase were purified from human liver, and some kinetic properties were examined in the direction of glycogen synthesis. The b form has a limited catalytic capacity, resembling that of the rabbit liver enzyme. It is characterized by a low affinity for glucose 1-phosphate, which is unaffected by AMP, and a low V, which becomes equal to that of the a form in the presence of the nucleotide. Lyotropic anions stimulate phosphorylase b and inhibit phosphorylase a by modifying the affinity for glucose 1-phosphate. Both enzyme forms are easily saturated with glycogen. 2. These kinetic properties have allowed us to design a simple assay method for total (a + b) phosphorylase in human liver. It requires only 0.5 mg of tissue, and its average efficiency is 90% when the enzyme is predominantly in the b form. 3. The assay of total phosphorylase allows the unequivocal diagnosis of hepatic glycogen-storage disease caused by phosphorylase deficiency. One patient with a complete deficiency is reported. 4. The assay of human liver phosphorylase a is based on the preferential inhibition of the b form by caffeine. The a form displays the same activity when measured by either of the two assays.

Citing Articles

Progressive liver disease and dysregulated glycogen metabolism in murine GSD IX γ2 models human disease.

Gibson R, Jeck W, Koch R, Mehta A, Choi S, Sriraman Y Mol Genet Metab. 2024; 143(4):108597.

PMID: 39488079 PMC: 11633833. DOI: 10.1016/j.ymgme.2024.108597.


Chronic liver disease and impaired hepatic glycogen metabolism in argininosuccinate lyase deficiency.

Burrage L, Madan S, Li X, Ali S, Mohammad M, Stroup B JCI Insight. 2020; 5(4).

PMID: 31990680 PMC: 7101134. DOI: 10.1172/jci.insight.132342.


High frequency of missense mutations in glycogen storage disease type VI.

Beauchamp N, Taybert J, Champion M, Layet V, Heinz-Erian P, Dalton A J Inherit Metab Dis. 2007; 30(5):722-34.

PMID: 17705025 DOI: 10.1007/s10545-007-0499-9.


Mutations in the liver glycogen phosphorylase gene (PYGL) underlying glycogenosis type VI.

Burwinkel B, Bakker H, Herschkovitz E, Moses S, Shin Y, Kilimann M Am J Hum Genet. 1998; 62(4):785-91.

PMID: 9529348 PMC: 1377030. DOI: 10.1086/301790.


Radiochemical methods for the assay of phosphorylase in the direction of glycogenolysis.

Gevers G, Stalmans W Biochem J. 1981; 193(3):793-8.

PMID: 7305961 PMC: 1162668. DOI: 10.1042/bj1930793.


References
1.
YUNIS A, KREBS E . Comparative studies on glycogen phosphorylase. II. Immunological studies on rabbit and human skeletal muscle phosphorylase. J Biol Chem. 1962; 237:34-9. View

2.
Hughes R, YUNIS A, KREBS E, FISCHER E . Comparative studies on glycogen phosphorylase. III. The phosphorylated site in human muscle phosphorylase alpha. J Biol Chem. 1962; 237:40-3. View

3.
YUNIS A, FISCHER E, KREBS E . Crystallization and properties of human muscle phosphorylases a and b. J Biol Chem. 1960; 235:3163-8. View

4.
HERS H . [Enzymatic studies of hepatic fragments; application to the classification of glycogenoses]. Rev Int Hepatol. 1959; 9(1):35-55. View

5.
Stalmans W . The role of the liver in the homeostasis of blood glucose. Curr Top Cell Regul. 1976; 11:51-97. DOI: 10.1016/b978-0-12-152811-9.50009-2. View